Ophthalmic Solution of Smart Supramolecular Peptides to Capture Semaphorin 4D against Diabetic Retinopathy

Diabetic retinopathy (DR) is the leading cause of vision loss in working age population. Intravitreal injection of anti‐VEGF antibody is widely used in clinical practice. However, about 27% of patients show poor response to anti‐VEGF therapy and about 50% of these patients continue to have macular t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ya‐Nan, Liang, Hong‐Wen, Zhang, Chun‐Lin, Qiu, Yan‐Mei, Wang, David, Wang, Hai‐Ling, Chen, An‐Qi, Hong, Can‐Dong, Wang, Lei, Wang, Hao, Hu, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875641/
https://www.ncbi.nlm.nih.gov/pubmed/36437109
http://dx.doi.org/10.1002/advs.202203351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875641/
https://www.ncbi.nlm.nih.gov/pubmed/36437109
http://dx.doi.org/10.1002/advs.202203351

Ejemplares similares